Corbus Pharmaceuticals Holdings (CRBP) Cash from Operations (2013 - 2025)

Corbus Pharmaceuticals Holdings' Cash from Operations history runs 13 years deep, the most recent figure standing at 15550000.0 for Q3 2025.

• On a quarterly basis, Cash from Operations fell 11.53% year-over-year to 15550000.0 in Q3 2025; TTM through Sep 2025 was 59512000.0, a 61.45% decrease from a year earlier, with the FY2024 full-year figure at 41794000.0, down 15.77% from the prior year.
• Cash from Operations advanced to 15550000.0 in Q3 2025 per CRBP's latest filing, from 16599000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 856954.0 in Q3 2021 and bottomed at 21809505.0 in Q1 2021.
• The 5-year median for Cash from Operations is 10615350.0 (2022), against an average of 11168006.95.
• Across the five-year window, Cash from Operations surged 103.14% in 2021 and slumped 945.44% in 2022, its largest moves.
• Year by year, Cash from Operations stood at 9702575.0 in 2021, then advanced by 23.16% to 7454985.0 in 2022, then increased by 19.41% to 6008000.0 in 2023, then plunged by 82.12% to 10942000.0 in 2024, then plunged by 42.11% to 15550000.0 in 2025.
• Per Business Quant, the three latest CRBP Cash from Operations figures stand at 15550000.0 (Q3 2025), 16599000.0 (Q2 2025), and 16421000.0 (Q1 2025).